Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Agreements reached under this partnership
Business Alliance2385Soiken Holdings Inc.
Alliance partnerFlora株式会社
Details of the alliance
- 1
女性の健康課題に対する一体的支援サービスの提供
- 2
生体評価システム事業における調査・研究
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
About the partner
Business DescriptionAI/データを用いた健康・well-being の推進
Location京都市左京区
Share capital93,695,916円
Impact on Business Performance
当期の業績への影響については現在精査中
Contract Date2025年8月4日Alliance start date2025年8月8日（予定）
| Item | Details |
|---|---|
| Name of alliance partner | Flora株式会社 |
| Alliance partner's business activities | AI/データを用いた健康・well-being の推進 |
| Alliance partner's location | 京都市左京区 |
| Alliance partner's capital | 93,695,916円 |
| Type of alliance | Business Alliance |
| Details of the alliance | 女性の健康課題に対する一体的支援サービスの提供, 生体評価システム事業における調査・研究 |
| Contract Date | 2025年8月4日 |
| Alliance start date | 2025年8月8日（予定） |
| Impact on Business Performance | 当期の業績への影響については現在精査中 |
Items this document does not state (14)
Alliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionShare Acquisition Date and Payment DateChange in major shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Floraの「Wellflow」とMedifellowのオンライン健康相談サービス、当社グループの専門医ネットワークおよびラクトフェリンを組み合わせ、PMS・更年期・妊活などに対する相談・診療・セルフケアを一体的に提供することで、企業・健康保険組合の健康経営を支援し、医療費適正化にも寄与するため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.